Patients can order molnupiravir by consulting with a doctor on the HealthNow app to check eligibility.
It was approved by the Food and Drug Administration just last month, provided that it should be used for at-risk patients. The antiviral drug helps treat mild to moderate COVID-19 cases. It’s only available for patients 18 years old and above with “risk factors for developing severe illness” such as senior citizens and those with comorbidities.”
HealthNow is developed by Ayala Healthcare Holdings, Inc. (AC Health) and Globe’s 917Ventures, which aimed to provide a platform for delivering primary care services, including health teleconsultation and medicine orders hassle-free online.